The normobaric oxygen paradox: a novel way to administer oxygen as an adjuvant treatment for cancer?
par De Bels, David
;Corazza, Francis
;Germonpré, Peter;Balestra, Costantino 
Référence Medical hypotheses, 76, 4, page (467-470)
Publication Publié, 2011-04



Référence Medical hypotheses, 76, 4, page (467-470)
Publication Publié, 2011-04
Article révisé par les pairs
Titre: |
|
Auteur: | De Bels, David; Corazza, Francis; Germonpré, Peter; Balestra, Costantino |
Informations sur la publication: | Medical hypotheses, 76, 4, page (467-470) |
Statut de publication: | Publié, 2011-04 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Administration, Inhalation |
Chemotherapy, Adjuvant -- methods | |
Erythropoietin -- genetics | |
Gene Expression -- drug effects | |
Humans | |
Hypoxia-Inducible Factor 1, alpha Subunit -- genetics | |
Neoplasms -- blood supply -- drug therapy | |
Neovascularization, Pathologic -- drug therapy -- genetics | |
Oxygen -- administration & dosage | |
Vascular Endothelial Growth Factor A -- genetics | |
Note générale: | Journal Article |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0306-9877 |
info:doi/10.1016/j.mehy.2010.11.022 | |
info:pii/S0306-9877(10)00485-8 | |
info:scp/79952315399 | |
info:pmid/21146939 |